Healthcare provider profile · identity verified

Mabel Vasquez, M.D.

Internal Medicine · LOS ANGELES, CA · NPI 1811929128

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	724	209
Levothyroxine Sodium	Levothyroxine Sodium	442	110
Atorvastatin Calcium	Atorvastatin Calcium	341	97
Rosuvastatin Calcium	Rosuvastatin Calcium	326	100
Losartan Potassium	Losartan Potassium	305	91
Montelukast Sodium	Montelukast Sodium	270	84
Gabapentin	Gabapentin	220	73
Omeprazole	Omeprazole	219	68
Metformin Hcl	Metformin Hcl	188	61
Famotidine	Famotidine	186	64
Ozempic	Semaglutide	184	30
Diclofenac Sodium	Diclofenac Sodium	172	66
Tamsulosin Hcl	Tamsulosin Hcl	158	47
Lisinopril	Lisinopril	156	45
Benazepril Hcl	Benazepril Hcl	141	39
Duloxetine Hcl	Duloxetine Hcl	125	42
Pregabalin	Pregabalin	124	48
Fluticasone Propionate	Fluticasone Propionate	122	36
Jardiance	Empagliflozin	121	25
Pantoprazole Sodium	Pantoprazole Sodium	119	39
Januvia	Sitagliptin Phosphate	117	33
Simvastatin	Simvastatin	113	34
Synthroid	Levothyroxine Sodium	110	25
Hydrochlorothiazide	Hydrochlorothiazide	106	34
Labetalol Hcl	Labetalol Hcl	104	25
Citalopram Hbr	Citalopram Hydrobromide	102	27
Metformin Hcl Er	Metformin Hcl	102	33
Baclofen	Baclofen	98	38
Escitalopram Oxalate	Escitalopram Oxalate	98	25
Mirtazapine	Mirtazapine	97	26
Alprazolam	Alprazolam	96	35
Farxiga	Dapagliflozin Propanediol	94	26
Trazodone Hcl	Trazodone Hcl	93	24
Metoprolol Tartrate	Metoprolol Tartrate	89	26
Alendronate Sodium	Alendronate Sodium	84	23
Trulicity	Dulaglutide	81	18
Furosemide	Furosemide	80	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	78	20
Sertraline Hcl	Sertraline Hcl	71	14
Tramadol Hcl	Tramadol Hcl	71	15
Glimepiride	Glimepiride	67	16
Metoprolol Succinate	Metoprolol Succinate	67	18
Pravastatin Sodium	Pravastatin Sodium	67	21
Finasteride	Finasteride	60	18
Cetirizine Hcl	Cetirizine Hcl	57	30
Buspirone Hcl	Buspirone Hcl	56	19
Eliquis	Apixaban	51	13
Mounjaro	Tirzepatide	50	14
Clotrimazole	Clotrimazole	49	27
Lidocaine	Lidocaine	47	16
Hydralazine Hcl	Hydralazine Hcl	46	17
Sumatriptan Succinate	Sumatriptan Succinate	43	suppressed
Atenolol	Atenolol	41	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	14
Vascepa	Icosapent Ethyl	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Albuterol Sulfate Hfa	Albuterol Sulfate	36	13
Carvedilol	Carvedilol	36	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	12
Allopurinol	Allopurinol	35	12
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Myrbetriq	Mirabegron	34	11
Bupropion Xl	Bupropion Hcl	31	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Valsartan	Valsartan	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	11
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Lactulose	Lactulose	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Potassium Chloride	Potassium Chloride	26	suppressed
Estradiol	Estradiol	25	11
Ciclopirox	Ciclopirox	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Azithromycin	Azithromycin	17	15
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fluconazole	Fluconazole	17	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Glipizide	Glipizide	16	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Serostim	Somatropin	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Isentress	Raltegravir Potassium	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error